VBI Vaccines: EC OKs Marketing Authorisation for 3-Antigen Adult Hepatitis B Vaccine

 

• PreHevbri™ is the only approved 3-antigen hepatitis B vaccine for adults in the EU and EEA
• Approval follows the positive opinion granted by European Committee for Medicinal Products for Human Use (CHMP) in February 2022
• Regulatory review in the United Kingdom is ongoing as part of the European Commission Decision Reliance Procedure

https://www.biospace.com/article/releases/vbi-vaccines-announces-european-commission-marketing-authorisation-for-prehevbri-a-3-antigen-adult-hepatitis-b-vaccine/